Targeting immunometabolism mediated by the IDO1 Pathway: A new mechanism of immune resistance in endometrial cancer

Immunotherapy is acquiring a primary role in treating endometrial cancer (EC) with a relevant benefit for many patients. Regardless, patients progressing during immunotherapy or those who are resistant represent an unmet need. The mechanisms of immune resistance and escape need to be better investig...

Descripción completa

Detalles Bibliográficos
Autores principales: Passarelli, Anna, Pisano, Carmela, Cecere, Sabrina Chiara, Di Napoli, Marilena, Rossetti, Sabrina, Tambaro, Rosa, Ventriglia, Jole, Gherardi, Federica, Iannacone, Eva, Venanzio, Sergio Setola, Fiore, Francesco, Bartoletti, Michele, Scognamiglio, Giosuè, Califano, Daniela, Pignata, Sandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479093/
https://www.ncbi.nlm.nih.gov/pubmed/36119020
http://dx.doi.org/10.3389/fimmu.2022.953115

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479093/
https://www.ncbi.nlm.nih.gov/pubmed/36119020
http://dx.doi.org/10.3389/fimmu.2022.953115

Ejemplares similares